Sökning: onr:"swepub:oai:DiVA.org:uu-16636" >
[11C]-PIB imaging i...
[11C]-PIB imaging in patients with Parkinson's disease : preliminary results
-
- Johansson, Anders (författare)
- Uppsala universitet,Neurologi
-
- Savitcheva, Irina (författare)
- Uppsala universitet,Institutionen för medicinska vetenskaper
-
- Forsberg, Anders (författare)
- Karolinska Institutet
-
visa fler...
-
- Engler, Henry (författare)
- Uppsala universitet,Institutionen för medicinska vetenskaper
-
Långström, Bengt (författare)
-
Nordberg, Agneta (författare)
-
- Askmark, Håkan (författare)
- Uppsala universitet,Neurologi
-
visa färre...
-
(creator_code:org_t)
- Elsevier BV, 2008
- 2008
- Engelska.
-
Ingår i: Parkinsonism & Related Disorders. - : Elsevier BV. - 1353-8020 .- 1873-5126. ; 14:4, s. 345-347
- Relaterad länk:
-
https://urn.kb.se/re...
-
visa fler...
-
https://doi.org/10.1...
-
http://kipublication...
-
visa färre...
Abstract
Ämnesord
Stäng
- [11C]-PIB positron emission tomography ([11C]-PIB PET) is a sensitive marker of amyloid in Alzheimer's disease (AD), but its specificity has not been fully evaluated. Vascular amyloid-β deposition is common in Parkinson's disease (PD) and α-synuclein, the major component of the Lewy bodies in PD, forms amyloid fibrils. We investigated five apparently cognitively normal PD patients with [11C]-PIB PET. The results were compared to 16 patients with AD and six healthy controls from a previous study. [11C]-PIB retention was not significantly increased in our patients who all had early stage PD. Further studies of more advanced PD patients are warranted.
Nyckelord
- Parkinson's disease
- PET
- PIB
- Amyloid
- Lewy bodies
- α-Synuclein
Publikations- och innehållstyp
- ref (ämneskategori)
- art (ämneskategori)
Hitta via bibliotek
Till lärosätets databas